News & Insights | Access & Channel

This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

FDA removes safety restrictions on some CAR-T cancer therapies

What potential tariffs in pharma could do

The 2025 reconciliation bill could leave millions uninsured, analysis says

Survey reveals nearly half of consumers face prescription cost barriers

340B and an unsustainable status quo

LucyRx and Personify Health partner on GLP-1

Lilly's evolving direct-to-patient strategy

Digital patient engagement changing support programs for better outcomes

Americans value pharmacists but don’t leverage their expertise, survey reveals

Building a rare disease company from the ground up

Insourced, outsourced, or hybrid hub model?

Integration and tech at the forefront of market access, say Eisai and Celcuity

Stakeholders unite on cost analysis for medication adherence programs

Access Insider Contributor Guidelines

Pharmaceutical industry faces multiple challenges from government programs and regulations

PAN Foundation report shows concerning trends for patient access

Partnership redefines patient support in specialty pharmacy care

Better collaboration is needed among patient advocacy groups and biotech

When market access realities crimp a drug’s true value

Market access is key to investment

Quick Links